OBJECTIVE: To assess cognitive performance as a predictor of noncompletion of cardiac rehabilitation (CR) using a standardized verbal memory test. METHODS: This was a prospective cohort study of consecutive patients with coronary artery disease (n = 131) entering 1-year outpatient CR between April 2007 and May 2009. Verbal memory performance was assessed using the California Verbal Learning Test, Second Edition. Attendance at weekly CR sessions was recorded, and completion or noncompletion was determined according to comprehensive CR criteria. Depression was diagnosed according to DSM-IV criteria as a possible confounder. RESULTS: Verbal memory performance at entry into CR differed significantly (F(1,130) = 7.80, p = .006) between noncompleters and completers (mean [SD] cumulative California Verbal Learning Test, Second Edition, score, -1.15 [2.59] versus 0.47 [3.12]) in analysis of covariance controlling for pertinent clinical confounders. Better verbal memory performance predicted a reduced risk of noncompletion (hazard ratio [HR] = 0.86, 95% confidence interval [CI] = 0.77-0.96, p = .009) in time-to-event analysis adjusted for depression (HR = 2.62, 95% CI = 1.33-5.17, p = .006) and smoking history (HR = 2.03, 95% CI = 0.98-4.22, p = .06). A post hoc analysis suggested that better verbal memory performance predicted a reduced risk of noncompletion for medical reasons (HR = 0.83, 95% CI = 0.70-0.99, p = .03). CONCLUSIONS: Poorer verbal memory performance was associated with an increased risk of noncompletion of CR among participants with coronary artery disease. Further studies exploring practical methods for screening and targeted support might improve rehabilitation outcomes.
OBJECTIVE: To assess cognitive performance as a predictor of noncompletion of cardiac rehabilitation (CR) using a standardized verbal memory test. METHODS: This was a prospective cohort study of consecutive patients with coronary artery disease (n = 131) entering 1-year outpatient CR between April 2007 and May 2009. Verbal memory performance was assessed using the California Verbal Learning Test, Second Edition. Attendance at weekly CR sessions was recorded, and completion or noncompletion was determined according to comprehensive CR criteria. Depression was diagnosed according to DSM-IV criteria as a possible confounder. RESULTS: Verbal memory performance at entry into CR differed significantly (F(1,130) = 7.80, p = .006) between noncompleters and completers (mean [SD] cumulative California Verbal Learning Test, Second Edition, score, -1.15 [2.59] versus 0.47 [3.12]) in analysis of covariance controlling for pertinent clinical confounders. Better verbal memory performance predicted a reduced risk of noncompletion (hazard ratio [HR] = 0.86, 95% confidence interval [CI] = 0.77-0.96, p = .009) in time-to-event analysis adjusted for depression (HR = 2.62, 95% CI = 1.33-5.17, p = .006) and smoking history (HR = 2.03, 95% CI = 0.98-4.22, p = .06). A post hoc analysis suggested that better verbal memory performance predicted a reduced risk of noncompletion for medical reasons (HR = 0.83, 95% CI = 0.70-0.99, p = .03). CONCLUSIONS: Poorer verbal memory performance was associated with an increased risk of noncompletion of CR among participants with coronary artery disease. Further studies exploring practical methods for screening and targeted support might improve rehabilitation outcomes.
Authors: Mahwesh Saleem; Veera V Ratnam Bandaru; Nathan Herrmann; Walter Swardfager; Michelle M Mielke; Paul I Oh; Prathiba Shammi; Alexander Kiss; Norman J Haughey; Randal Rovinski; Krista L Lanctôt Journal: BMC Geriatr Date: 2013-12-12 Impact factor: 3.921
Authors: Mehnaz Ahmed; Nathan Herrmann; Jinghan Jenny Chen; Mahwesh Saleem; Paul I Oh; Ana C Andreazza; Alexander Kiss; Krista L Lanctôt Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Mahwesh Saleem; Nathan Herrmann; Walter Swardfager; Paul I Oh; Prathiba Shammi; Gideon Koren; Stan Van Uum; Alexander Kiss; Krista L Lanctôt Journal: Cardiovasc Psychiatry Neurol Date: 2013-01-16
Authors: Bradley J MacIntosh; Walter Swardfager; David E Crane; Nipuni Ranepura; Mahwesh Saleem; Paul I Oh; Bojana Stefanovic; Nathan Herrmann; Krista L Lanctôt Journal: PLoS One Date: 2014-03-12 Impact factor: 3.240
Authors: Graham Mazereeuw; Nathan Herrmann; Hongbin Xu; Daniel Figeys; Paul I Oh; Steffany A L Bennett; Krista L Lanctôt Journal: J Neuroinflammation Date: 2014-07-04 Impact factor: 8.322
Authors: Graham Mazereeuw; Nathan Herrmann; Paul I Oh; David W L Ma; Cheng Tao Wang; Alexander Kiss; Krista L Lanctôt Journal: J Clin Psychopharmacol Date: 2016-10 Impact factor: 3.153
Authors: Mahwesh Saleem; Nathan Herrmann; Adam Dinoff; Graham Mazereeuw; Paul I Oh; Benjamin I Goldstein; Alex Kiss; Prathiba Shammi; Krista L Lanctôt Journal: Psychosom Med Date: 2019 Feb/Mar Impact factor: 4.312